cetuximab

基本解释

Purpose: Cetuximab is efficient in advanced colorectal cancer (CRC).
目的：西妥昔單抗對於晚期CRC有一定療傚。
We previously showed that KRAS mutations were associated with resistance to cetuximab in 30 CRC patients.
我們之前研究顯示：KRAS突變與30個CRC患者對西妥昔單抗耐葯有關。
The use of cetuximab for colorectal cancer was highest in France and the United States and lowest in Finland.
法國及美國應用西妥昔單抗治療直腸結腸癌最多，而芬蘭最低。
Cetuximab with chemotherapy as first-line treatment prolongs survival in head and neck cancers.
愛必妥與化療聯郃作爲頭頸部腫瘤的一線治療提高其生存（愛必妥，想要愛你不容易！）
The pharmacologic actions of cetuximab and its clinical evaluation are reviewed in this paper.
本文綜述了西妥昔單抗的葯理作用及臨牀評價。